Implementation of laparoscopic hysterectomy for endometrial cancer over the past decade

Wollinga, Tim; Ezendam, Nicole P. M.; Eggink, Florine A.; Smink, Marieke; Hamont, Dennis van; Pijlman, Brenda; Boss, Erik A.; Robbe, Elisabeth J.; Ngo, Huy; Boll, Dorry; Mom, Constantijne H.; Aa, Maaike A. van der; Kruitwagen, Roy P.M.; Nijman, Hans W.; Pijnenborg, Johanna M.A.

doi:10.1186/s10397-018-1040-x

Cited by 8 publications

(4 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The transition from open to minimally invasive surgery has been documented in various countries (16,17). Although our analysis confirms the published data, two events occurred during our observation that should have changed the clinical management, namely the approval of ulipristal acetate in 2012 and the issuing of the FDA warning in 2014.…”

Section: Discussionsupporting

confidence: 85%

Choosing a Surgical Access Point for Hysterectomy: A Paradigm Shift Over a 10-Year Span

et al. 2020

View full text Add to dashboard Cite

Background: When choosing a surgical procedure for a hysterectomy, doctors and patients have various options in terms of the multiple surgical access points available. The aim of this study was to descriptively analyze developments concerning the surgical access point selected over the past 10 years at Ulm University Hospital, (south) Germany, assess the variables associated with the surgical method and explore any potential significant correlations that influence these surgical access routes. Explicitly, we wished to investigate whether the approval of ulipristal acetate and the warning issued by the Food and Drug Administration (FDA) in connection with its use changed existing trends.Material and Methods: This monocentric study retrospectively assessed data from all patients who underwent a hysterectomy due to a benign disease or endometrial cancer from January 2007 until December 2016.Results: Of the benign indications considered, myomas and descensus genitalis occurred most frequently (49.5 and 30.6%, respectively). The percentage of abdominal procedures declined from 61.4 to 13.4% between 2007 and 2016 for all hysterectomies, whilst it increased from 4.1 to 69.7% for laparoscopic hysterectomies. The rate of vaginal hysterectomies increased to 45.5% until 2013 and declined in the years afterwards. Laparoscopic assisted vaginal hysterectomies were comparatively rare.The trends in terms of surgical routes were similar for endometrial cancer. During the observation period, the share of abdominal hysterectomies fell from 100 to 11.3%, whilst the share of laparoscopic hysterectomies increased from 0 to 86.6%. The other two procedures were less frequently used.Use of the laparoscopic hysterectomy procedure also increased significantly after the FDA's 2014 warning. Ulipristal acetate may have tended to influence the process.Conclusion: Contrary to the national decrease in hysterectomy numbers, the annual number of hysterectomies at Ulm University Hospital remained stable during the observation period. Nevertheless, there was a clear shift in the preferred surgical routes for hysterectomy.

show abstract

Section: Discussionsupporting

confidence: 85%

Choosing a Surgical Access Point for Hysterectomy: A Paradigm Shift Over a 10-Year Span

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Among the patients with stages I and II endometrial cancer treated with surgery ( n = 8548), 28.3% underwent laparoscopic surgery. In the Netherlands, the proportion of patients with stages I and II endometrial cancer undergoing laparoscopic surgery gradually increased from 11% in 2006 to 85% in 2015 5 . Thus, laparoscopic surgery for endometrial cancer is expected to become more widespread in Japan.…”

Section: Discussionmentioning

confidence: 99%

“…In the Netherlands, the proportion of patients with stages I and II endometrial cancer undergoing laparoscopic surgery gradually increased from 11% in 2006 to 85% in 2015. 5 Thus, laparoscopic surgery for endometrial cancer is expected to become more widespread in Japan.…”

Section: Discussionmentioning

confidence: 99%

Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual patient report for 2017 and annual treatment report for 2012

Nagase

Ohta

Takahashi

et al. 2021

J of Obstet and Gynaecol

View full text Add to dashboard Cite

Aim To provide information including the trend of gynecological malignancies in Japan, we hereby present the Annual Patient Report for 2017 and the Annual Treatment Report for 2012, on the outcomes of patients who started treatment in 2012. Methods The Japan Society of Obstetrics and Gynecology maintains an annual tumor registry, where information on gynecological malignancies from various participating institutions is gathered. The data of patients whose treatment with gynecologic malignancies was initiated in 2017 were analyzed retrospectively. Survival of the patients who started treatment with cervical, endometrial and ovarian cancer in 2012 was analyzed by using the Kaplan‐Meier, log‐rank and Wilcoxon tests. Results Treatment was initiated in 2017 for 7710 patients with cervical cancer; 11 120 with endometrial cancer; 7029 with ovarian, tubal and peritoneal cancer; 2164 with ovarian borderline tumors; and with the others (213 vulvar cancer, 139 vaginal cancer, 366 uterine sarcoma, 41 uterine adenosarcoma and 131 trophoblastic diseases). This clinicopathological information was summarized as the patient annual report. The 5‐year survival rates of the patients with cervical cancer were 92.9, 75.5, 58.2 and 26.7% for stages I, II, III and IV, respectively. The 5‐year survival rates for the patients with endometrial cancer were 93.6, 85.6, 72.6 and 27.3% for stages I, II, III and IV, respectively. The 5‐year survival rates for the patients with ovarian cancer (surface epithelial‐stromal tumors) were 92.5, 83.5, 49.5 and 30.8% for stages I, II, III and IV, respectively. Conclusion The annual tumor report is an important survey that provides knowledge on gynecological malignancy trends in Japan.

show abstract

“…In contrast to our expectations, we found that patients scored higher on physical and role functioning than the normative population at baseline and at 12 months, with scores being comparable at 24 months. Perhaps, our different baseline findings may be partly explained by differences in the proportion of patients receiving laparoscopic hysterectomy because the implementation of laparoscopic hysterectomy increased steeply in the last decade, from 11% in 2006 to 85% in 2015 [38]. The PORTEC-2 trial was conducted between 2002 and 2006 and therefore, compared to our cohort, these patients likely received laparotomy more frequently, which is known to have more impact on functioning than laparoscopic hysterectomy.…”

Section: Discussionmentioning

confidence: 88%

Do age and comorbidity impair recovery during two years after treatment for endometrial cancer?

Walree

Hamaker

Rooij

et al. 2020

Journal of Geriatric Oncology

Self Cite

View full text Add to dashboard Cite

Implementation of laparoscopic hysterectomy for endometrial cancer over the past decade

Cited by 8 publications

References 33 publications

Choosing a Surgical Access Point for Hysterectomy: A Paradigm Shift Over a 10-Year Span

Choosing a Surgical Access Point for Hysterectomy: A Paradigm Shift Over a 10-Year Span

Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual patient report for 2017 and annual treatment report for 2012

Do age and comorbidity impair recovery during two years after treatment for endometrial cancer?

Contact Info

Product

Resources

About